Regulus Therapeutics Inc. buy melinda
Start price
28.01.17
/
50%
€162.36
Target price
04.04.17
€346.37
Performance (%)
6.33%
End price
04.04.17
€172.64
Summary
This prediction ended on 04.04.17 with a price of €172.64. The BUY prediction by melinda finished with a performance of 6.33%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Regulus Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | -0.436% | 1.181% | 14.210% | 57.331% |
| iShares Nasdaq 100 | 0.854% | 1.475% | 5.797% | 88.129% |
| iShares Nikkei 225® | 2.652% | 6.401% | 19.133% | 49.690% |
| iShares S&P 500 | 1.190% | 1.169% | 2.686% | 59.994% |
According to melinda what are the pros and cons of Regulus Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Regulus Therapeutics Inc. diskutieren
Stopped prediction by melinda for Regulus Therapeutics Inc.
Regulus Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.44
16.10.21
16.10.21
€8.00
16.10.22
16.10.22
-62.16%
17.10.22
17.10.22
Could be worthwhile Investment >10% per year
Regulus Therapeutics Inc.
Start price
Target price
Perf. (%)
€11.30
12.01.20
12.01.20
-
04.11.21
04.11.21
-60.71%
16.10.21
16.10.21
Could be worthwhile Investment >10% per year
Regulus Therapeutics Inc.
Start price
Target price
Perf. (%)
€17.95
24.10.18
24.10.18
€27.06
22.01.19
22.01.19
-45.73%
22.01.19
22.01.19
Could be worthwhile Investment >10% per year
Regulus Therapeutics Inc.
Start price
Target price
Perf. (%)
€273.85
28.06.16
28.06.16
€541.20
19.07.16
19.07.16
36.36%
19.07.16
19.07.16
Could be worthwhile Investment >10% per year